Consultant-led education

Assessing the risk, diagnosing and grading VOD

Develop your understanding of the impact of monitoring for VOD, as well as its risk factors, diagnostic criteria, grading and prognosis.

Topics:

Case studies Diagnosis and severity grading Disease fundamentals Risk assessment and monitoring Treatment

ADVERSE EVENTS REPORTING

Adverse events should be reported. Reporting forms and information for the UK can be found at: https://yellowcard.mhra.gov.uk/

For Ireland, reporting forms and information can be found at: www.hpra.ie

Adverse events should also be reported to Jazz Pharmaceuticals at: AEreporting@jazzpharma.com

Defitelio® is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstruction syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy. It is indicated in adults and in adolescents, children and infants over 1 month of age.